Dr. Jonathan W. Rick, MD

Dr. Rick practices at Berman Skin Institute Medical Group Inc in Los Altos, California.

Dr. Rick's NPI, 1710440169, was assigned on April 12, 2019. Dr. Rick graduated from UCSF School of Medicine in 2018. Dr. Rick holds California license A182777.

Dr. Rick's primary practice is Berman Skin Institute Medical Group Inc, at 4300 El Camino Real, Los Altos, CA 94022 in Santa Clara County. The practice phone is (650) 325-6000.

Dr. Rick's primary practice is Berman Skin Institute Medical Group Inc in Los Altos, California. Dr. Rick is also affiliated with UC Davis Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Rick to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rick practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Rick's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rick is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Rick's licenses on file in 2 states: California and Arkansas.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes, psoriasis, rash and scalp rash among the conditions Dr. Rick treats.

CMS data shows 9,878 Medicare services from Dr. Rick across 28 procedure codes in 2024, for 2,156 Medicare patients. Medicare paid $478,619 for them. Every service was in an office.

CMS counts 2,156 Medicare patients who saw Dr. Rick in 2024. The largest group is 65 to 74, with 1,085 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rick's median patient age at 60, with 58% women.

In 2024, Dr. Rick wrote 1,231 Medicare Part D claims for 571 patients. 93% of them were for generic drugs. CMS names the drug for 1,104 of them, across 20 drugs with 11 or more claims each, at $207,537 in total drug cost. In 2023, CMS named 262 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rick for performance year 2024, reported as part of a group. Dr. Rick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rick as offering telehealth. CMS counts 515 procedures of skin biopsy by Dr. Rick, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Rick, published from 2016 to 2023. 2018 was the busiest year, with 5. The most frequent topics are Brain Neoplasms, Glioblastoma and Brain Injuries, Traumatic. Dr. Rick has published most often in J Neurosurg. Dr. Rick's most frequent co-authors are Manish Kumar Aghi, MD, PhD, Michael W. McDermott, MD and Ethan Andrew Winkler, MD, PhD.

CMS Open Payments shows 70 general payments to Dr. Rick from 13 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 73% of the total. Incyte Corporation paid the most, $9,247.

Dr. Rick graduated from UCSF School of Medicine in 2018.

Dr. Rick is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.